Respicardia

Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.
Type
Private
HQ
Hopkins, US
Founded
2006
Employees
20 (est)
Respicardia was founded in 2006 and is headquartered in Hopkins, US

Key People at Respicardia

Bonnie Labosky

Bonnie Labosky

President and CEO
Tim Hauch

Tim Hauch

Chief Financial Officer
Todd Goblish

Todd Goblish

Vice President of Research and Development
Robin Germany

Robin Germany

Chief Medical Officer
Jay Millerhagen

Jay Millerhagen

Vice President of Clinical Affairs and Market Development

Respicardia Locations

Hopkins, US

Respicardia Metrics

Respicardia Summary

Founding Date

2006

Total Funding

$107 M

Latest funding size

$20 M

Time since last funding

about 2 years

Investors

Respicardia's latest funding round of $20 M was in October 2014. In total, Respicardia has raised $107 M.
29% of current employees of Respicardia are female and 71% are male.

Respicardia Company Life